Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

NCT04630015 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04630015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04630015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
August 31, 2020
Completion date
May 1, 2023
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 infection, hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm